Antifibrotic drug discovery [E-Book] / edited by Jehrod Brenneman and Malliga R. Iyer.
Fibrosis is a condition with globally high unmet medical need, and as such is a highly active area of academic and pharmaceutical research covering multiple treatment targets, organs, tissues and therapeutic approaches. Anti-fibrotic Drug Discovery is a single source reference for the latest drug-di...
Saved in:
Full text |
|
Personal Name(s): | Brenneman, Jehrod, editor |
Iyer, Malliga R., editor | |
Imprint: |
London :
Royal Society of Chemistry,
2020
|
Physical Description: |
1 online resource (xvi, 347 pages). |
Note: |
englisch |
ISBN: |
9781788015103 9781839160516 1839160519 9781788015783 178801510X 1788015789 |
Series Title: |
/* Depending on the record driver, $field may either be an array with
"name" and "number" keys or a flat string containing only the series
name. We should account for both cases to maximize compatibility. */?>
RSC drug discovery series ;
73 |
Subject (LOC): |
- TGFβ Signaling
- Targeting the αv Integrins in Fibroproliferative Disease
- Discovery, Structural Refinement and Therapeutic Potential of Farnesoid X Receptor Activators
- Autotaxin Inhibitors in Fibrosis
- Inhibition of LOXL2 and Other Lysyl Oxidase (Like) Enzymes: Intervention at the Core of Fibrotic Pathology
- Targeting the Ubiquitin Proteasome System in Pulmonary Fibrosis
- Galectin-3 Involvement in Fibrotic Diseases
- Emerging Role of CXCR4 in Fibrosis
- BH3 Mimetic Drugs for Anti-fibrotic Therapy
- Intratumoral Fibrosis: Emerging Concepts and Therapeutic Opportunities
- Targeting Fibroblasts in Fibrosis and Cancer